EverPrime vs Maximus
In our scoring, Maximus edges ahead overall (7.6 vs 7.2 out of 10), and Maximus costs less for compounded semaglutide (about $237 a year less; one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost).
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Key differences
- Price
- Maximus $249.99/mo vs EverPrime $249/mo for compounded semaglutide (standing prices, no prepay or separate membership listed · about $237 a year less with Maximus · one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
- Coverage
- Maximus 50 states + DC (EverPrime doesn't publish a state list)
- Included
- EverPrime: medication, clinician visits, shipping, labs; Maximus: medication, shipping
- Safety
- FDA warning letters on record: EverPrime none, Maximus 1
EverPrime
Affiliate partnerBest for compounded GLP-1 care with labs and provider visits included, from the company behind Enhance MD
semaglutide
$249
billed every 4 weeks
Our score 7.2/10
Maximus
Affiliate partnerBest for men seeking compounded GLP-1 alongside testosterone optimization
semaglutide
$249.99
Our score 7.6/10
We may earn a commission if you sign up through these links. Partner status can affect which provider we feature; it never changes a score or a price.
Costs & coverage
Published prices with their terms attached. Yearly figures are modeled from the standing price and billing cadence. A check mark marks the better side, on like-for-like rows only.
EverPrime
Maximus
Price
Semaglutide / month
$249/mo
billed every 4 weeks
Better on this row: $249.99/mo
Semaglutide / year (modeled)
$3,237
13 charges
Better on this row: $3,000
Tirzepatide / month
Better on this row: $329/mo
billed every 4 weeks
$359.99/mo
Tirzepatide / year (modeled)
Better on this row: $4,277
13 charges
$4,320
Brand Wegovy / Ozempic / month
Not listed
$349.99/mo
starting dose
Brand Zepbound / Mounjaro / month
Not listed
$449.99/mo
starting dose
Brand Wegovy pill / Rybelsus / month
Not listed
$249.99/mo
starting dose
Brand Foundayo / month
Not listed
$199.99/mo
starting dose
Coverage
State availability
List not published
50 states + DC
Oral option listed
Not listed
Yes
Brand-name access listed
Not listed
Wegovy / Ozempic, Zepbound / Mounjaro, Wegovy pill / Rybelsus, Foundayo
Included in the price
Medication, clinician visits, shipping, labs
Medication, shipping
FSA/HSA accepted
Yes
Not listed
Terms & safety
Price shown
Before intake
Before intake
Lab work
Required
Not disclosed
Video visit
Not disclosed
Required
Cancel anytime
Yes
Yes
Minimum commitment
None on the 1-month plan; 3-, 6- and 12-month plans are paid upfront
None
Refunds
Full refund if a provider decides treatment isn't right for you; prepaid membership and plan payments are non-refundable; no refund once pharmacy preparation starts
Not disclosed
FDA warning letters
Better on this row: None on record
1 warning letter
Provider facts checked
October 2026
August 2026
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 500+ providers' prices on their own sites and email you when tracked prices move.
Which fits your priorities?
Only the points where these two differ, from the table above and each provider’s record.
Choose EverPrime if…
- No FDA warning letters on record (Maximus has 1)
- Accepts FSA/HSA cards
- Names its operator, Enhance.MD, LLC, plus its medical groups and dispensing pharmacies in its terms
What to weigh up
- About $237 a year more than Maximus for compounded semaglutide (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
- No published state list; confirm yours at signup
Choose Maximus if…
- About $237 a year less than EverPrime for compounded semaglutide at standing prices (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
- Lists brand-name Wegovy / Ozempic, brand-name Zepbound / Mounjaro and brand-name Wegovy pill / Rybelsus, which EverPrime doesn't price
- Publishes its full state list (50 states + DC)
What to weigh up
- 1 FDA warning letter on record
- No LegitScript or PCAB certification found
Explore the scoring factors
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
EverPrime
7.2/10
Maximus
7.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Ivim Health
Compounded GLP-1 with weekly provider check-ins and health coaches, under a required monthly membership
Read full review →From $65/mo (+ required membership)
Get started →From $247/mo (after intro offer)
Get started →From $139/mo (4-month plan rate)
Get started →EverPrime vs Maximus: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring EverPrime and Maximus head-to-heads in the same category.
- EverPrime vs Amazon One Medical
- EverPrime vs Vytora Health
- EverPrime vs CoreAge Rx
- Maximus vs Amazon One Medical
- Maximus vs Vytora Health
- Maximus vs CoreAge Rx
Or see the full category ranking, or alternatives to EverPrime and Maximus.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.